Public Profile

INSYS Therapeutics, Inc.

INSYS Therapeutics, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2010, the company has made significant strides in developing innovative therapies, particularly in the areas of pain management and substance use disorders. INSYS is renowned for its unique delivery systems, including sublingual formulations that enhance the bioavailability of cannabinoids. Their flagship products, such as Syndros, have positioned the company as a leader in the treatment of chemotherapy-induced nausea and vomiting. With a commitment to advancing patient care, INSYS Therapeutics has achieved notable milestones, including successful FDA approvals and a growing portfolio of proprietary products. The company continues to focus on addressing unmet medical needs, solidifying its market position in the evolving landscape of therapeutics.

DitchCarbon Score

How does INSYS Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

INSYS Therapeutics, Inc.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

INSYS Therapeutics, Inc.'s reported carbon emissions

INSYS Therapeutics, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions data, it is challenging to assess their carbon footprint or climate commitments. However, the absence of reported figures suggests that the company may still be in the early stages of developing a comprehensive sustainability strategy. In the pharmaceutical industry, companies are increasingly recognising the importance of addressing climate change and setting measurable targets to reduce their environmental impact. As such, INSYS Therapeutics may need to establish clear climate commitments and reduction initiatives to align with industry standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. INSYS Therapeutics, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for INSYS Therapeutics, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

INSYS Therapeutics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Kyowa Kirin

JP
Pharmaceutical Preparation Manufacturing
Updated about 16 hours ago

Mallinckrodt Inc. (New York)

US
Updated 3 months ago
DitchCarbon Score

Heron Therapeutics, Inc.

US
Health and social work services (85)
Updated 2 days ago

Allergan Finance, LLC

US
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Glaxosmithkline

GB
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Tesaro, Inc.

US
Health and social work services (85)
Updated 3 months ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers